Stay updated on Troriluzole for Spinocerebellar Ataxia Clinical Trial

Sign up to get notified when there's something new on the Troriluzole for Spinocerebellar Ataxia Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Troriluzole for Spinocerebellar Ataxia Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.3%
    Check dated 2025-04-30T19:40:38.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.15.0, replacing the previous version 2.14.4.
    Difference
    1.0%
    Check dated 2025-04-16T13:24:49.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for February 10, 2025, while a date for March 25, 2025, has been removed.
    Difference
    1.0%
    Check dated 2025-04-09T06:51:38.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    5%
    Check dated 2025-02-24T20:28:18.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    The study on Troriluzole in adult participants with Spinocerebellar Ataxia has been updated to reflect that results have been posted, moving from a previous status of results submitted. Additionally, the date has been changed from January 25, 2024, to February 10, 2025.
    Difference
    2%
    Check dated 2025-02-17T14:38:18.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    The page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.
    Difference
    6%
    Check dated 2025-02-10T09:39:21.000Z thumbnail image

Stay in the know with updates to Troriluzole for Spinocerebellar Ataxia Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Troriluzole for Spinocerebellar Ataxia Clinical Trial page.